MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-08-0018686
Sibli Pharma Private Limited
Sibli Pharma Private Limited - pharma in Uluberia, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.99 Cr
▲ 37% YoY
Net profit · FY 2025
₹6.62 Lakh
Net margin 1.3%
EBITDA · FY 2025
₹11.94 Lakh
EBITDA margin 2.4%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Open charges
₹74.5 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
About Sibli Pharma Private Limited
Data last updated:
Sibli Pharma Private Limited is a private limited company based in Uluberia, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24100WB2021PTC247248. Its GSTIN is 19ABGCS6670Q1ZC (West Bengal).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Samir Kumar Shee and Swapna Shee.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Samir Kr. Shee Hatkaliganj Near Uluberia Municipality Swimming Pool, West Bengal, India – 711315.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.99 Cr, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹6.62 Lakh (net margin 1.3%) and EBITDA of ₹11.94 Lakh (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 209% over three years.
As per MCA filings, the company has open charges of ₹74.5 Lakh on record.
Sibli Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-08-0018686).
Company details
CIN U24100WB2021PTC247248
Registration Number 247248
Incorporation Date 16 August 2021
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-WB-08-0018686
Key People
Samir Kumar Shee Director Swapna Shee Director Recognitions & Rankings of Sibli Pharma
Contact details
Sibli Pharma Private Limited's registered office is in Uluberia, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Samir Kr. Shee Hatkaliganj Near Uluberia Municipality Swimming Pool, West Bengal, India – 711315
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sibli Pharma Private Limited, buy the company report.
Comprehensive company report
Sibli Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sibli Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sibli Pharma Private Limited, buy the company report.
Financials of Sibli Pharma Private Limited
FY 2025 filings availableSibli Pharma Private Limited reported revenue of ₹4.99 Cr (up 37% YoY) for FY 2025.
Revenue · FY 2025
₹4.99 Cr ▲ 37%
Net profit · FY 2025
₹6.62 Lakh margin 1.3%
EBITDA · FY 2025
₹11.94 Lakh margin 2.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 209%
EBITDA CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 184%
Revenue has grown at a compounded annual rate (CAGR) of 209% over three years, including 37% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹11.94 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹6.62 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.4% | |||
| Net Profit Margin | 1.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Sibli Pharma Private Limited, buy the company report.
Board of directors of Sibli Pharma Private Limited
Sibli Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samir Kumar Shee | Director | 16 Aug 2021 | 5 Years 2 Months | Current |
| Swapna Shee | Director | 16 Aug 2021 | 5 Years 2 Months | Current |
Peer comparison
Sibli Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Saltcare Pharmaceuticals Private Limited | ₹5 Cr (FY 2024) | 25.0% | Gorakhpur, Uttar Pradesh, India | |||
| Harrissa Healthcare Private Limited | ₹4.99 Cr (FY 2025) | 19.0% | Jaipur, Rajasthan, India | |||
| Sibli Pharma Private Limitedthis company | ₹4.99 Cr (FY 2025) | ₹6.62 Lakh | 1.3% | 37.0% | Uluberia, West Bengal, India | |
| Wellix Healthcare Private Limited | ₹4.98 Cr (FY 2025) | 2.0% | Jamshedpur, Jharkhand, India |
To see the full peer comparison of Sibli Pharma Private Limited, buy the company report.
Auditor
Sibli Pharma Private Limited is audited by SOUMYADUTTA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SOUMYADUTTA | FY 2023 | 309867 |
Shareholding
The shareholding of Sibli Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sibli Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹74.5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Jul 2024 | 100961193 | Hdfc Bank Limited | ₹65 Lakh | Open | |
| 02 May 2022 | 100598530 | Bank of India | ₹9.5 Lakh | Open |
To see the full charge records of Sibli Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Sibli Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sibli Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sibli Pharma Private Limited has 1 active EPFO establishment as of Mar 29, 2024.
Active EPFO establishments
1
GST
Sibli Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19ABGCS6670Q1ZC | West Bengal | Active | 01 Nov 2021 |
To see the full GST registrations and return filing status of Sibli Pharma Private Limited, buy the company report.
Recent activity
Sibli Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Samir Kumar Shee was appointed as Director on 16 Aug 2021.
AGM
Sibli Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 65.00 Lakh registered on 06 Jul 2024 with Charge ID 100961193 was modified on 05 Apr 2025.
Filing
Sibli Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 65.00 Lakh with Charge ID 100961193 was registered on 06 Jul 2024.
Charges
A charge with Bank Of India amounted to Rs. 9.50 Lakh with Charge ID 100598530 was registered on 02 May 2022.
Appointed
Samir Kumar Shee was appointed as Director.
Appointed
Swapna Shee was appointed as Director.
Incorporation
16 Aug 2021
Sibli Pharma Private Limited was registered on 16 Aug 2021 with Roc Kolkata & aged 5 years 2 months as per MCA records.
Frequently asked questions
Sibli Pharma is an active private limited company based in Uluberia, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 August 2021 (5+ years old) and is registered under CIN U24100WB2021PTC247248.
Sibli Pharma has 2 current directors:
- Samir Kumar Shee - Director
- Swapna Shee - Director
The latest financial statements of Sibli Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Sibli Pharma is 19ABGCS6670Q1ZC, registered in West Bengal.
The CIN (Corporate Identification Number) of Sibli Pharma is U24100WB2021PTC247248. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sibli Pharma was incorporated on 16 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Sibli Pharma by revenue are Saltcare Pharmaceuticals Private Limited, Harrissa Healthcare Private Limited, Wellix Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Samir Kumar Shee was appointed as Director on 16 Aug 2021. Swapna Shee was appointed as Director on 16 Aug 2021.
Yes, Sibli Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-08-0018686).
The registered office of Sibli Pharma is at CO Samir Kr. Shee Hatkaliganj Near Uluberia Municipality Swimming Pool, West Bengal, India – 711315.
Sibli Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.